Skip to content

Biolivon publishes the science.

Biolivon
Peptide Library

Every dossier, same structure, evidence graded

Each entry states what a compound is, how it is proposed to work, what human and preclinical research exists, what the safety picture looks like, where it stands with regulators in each country, and what remains genuinely unknown.

Browse 46 dossiersHow we grade evidence
  • Source-linked
  • Named reviewers
  • Status by country
  • Unknowns stated
Most compounds in this library are not approved for human use. A dossier is a summary of research, not an endorsement, and never a protocol. We do not publish dosing or administration instructions for unapproved compounds. Biolivon does not sell peptides.

What the grades mean

How we assign and change grades

Established
Supported by substantial human evidence for the stated context.
Tested, no benefit
Adequately tested in humans and did not show the claimed benefit. This is knowledge, not missing evidence — a different thing from Insufficient.
Promising
Positive human evidence, but limited in scale or replication.
Preliminary
Early or exploratory human evidence only.
Preclinical
Primarily animal or laboratory evidence. No adequate human data.
Insufficient
Evidence is too weak, too small or too inconsistent to judge.
Safety concern
Meaningful unresolved safety or regulatory concerns.

Showing 46 of 46 dossiers. Evidence grade describes the strength of the research, not a recommendation to use anything.